Vascular Anomaly Pathology and Genomics Biopsy Study

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Vascular MalformationsVascular AnomalyHemangiomaArteriovenous MalformationsVenous MalformationKlippel Trenaunay SyndromeLymphatic Malformation
Interventions
PROCEDURE

Percutaneous Vascular Anomaly/Malformation Biopsy

US-guided percutaneous vascular anomaly core needle biopsy of up to 10 cores using an 18-gauge co-axial core needle biopsy device at the time of clinically indicated sclerotherapy, embolization or ablation treatment.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study | Biotech Hunter | Biotech Hunter